Floatz logo

HYALURONATE

Alpha 1-Antitrypsin Deficiency

Gerard Turinoother_biologicalPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Alpha 1-Antitrypsin Deficiency cohort.

Asset / SponsorPhaseRating
Alpha-1-Proteinase Inhibitor
Grifols Therapeutics LLC
Phase 4A
.ALPHA.-1 PROTEASE INHIBITOR
Grifols Therapeutics LLC
Phase 4A
Raav1-Cb-Haat
Beacon Therapeutics
Phase 2BB
Aro-Aat
Arrowhead Pharmaceuticals
Phase 2BB
Alvelestat
University of Alabama at Birmingham
Phase 2B

View all 21 →

Same molecule, other indications

HYALURONATE is also rated in:

Osteoarthritis of KneeDormant
BBB
Indicative ·
75 / 100
View asset →
osteoarthritis, kneeDormant
BB
Indicative ·
68 / 100
View asset →
chronic pain syndromeDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →